Erytech Pharma ADR (ERYP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ERYP | AMGN | BMY | VRTX | GILD |
| Company | Erytech Pharma ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.8200 | 264.22 | 58.84 | 464.00 | 90.34 |
| High | 0.8800 | 280.34 | 59.08 | 467.96 | 91.68 |
| Low | 0.7800 | 257.80 | 58.06 | 459.07 | 89.63 |
| Last | 0.7800 | 280.01 | 58.74 | 467.07 | 91.35 |
| Change | unch | -13.99 | -0.04 | +5.36 | +0.86 |
| % Change | unch | -4.76% | -0.07% | +1.16% | +0.95% |
| Volume | 3,200 | 17,008,600 | 7,432,822 | 1,327,700 | 4,406,300 |
| 20-Day Average Volume | 10,460 | 3,916,380 | 12,645,005 | 1,458,055 | 7,596,800 |
| Previous Close | 0.7800 | 294.00 | 58.78 | 461.71 | 90.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8371 | 303.34 | 56.89 | 477.00 | 91.20 |
| 20-Day Raw Stochastic | 27.72% | 31.53% | 73.38% | 29.47% | 41.11% |
| 20-Day Relative Strength | 44.78% | 33.49% | 61.65% | 47.51% | 57.10% |
| Weighted Alpha | -61.10 | -4.66 | +26.62 | +24.37 | +26.21 |
| Today's Opinion | 8% Sell | 72% Sell | 100% Buy | 8% Sell | 96% Buy |
| Previous Opinion | 8% Sell | 72% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 72% Buy | 8% Buy | 72% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.86% since 06/21/23 | +0.02% since 11/19/24 | +0.88% since 11/19/24 | +4.25% since 11/19/24 | +4.10% since 11/19/24 |
| Low | 0.7110 on 06/27/23 | 257.80 on 11/26/24 | 57.47 on 11/21/24 | 445.00 on 11/21/24 | 87.77 on 11/20/24 |
| High | 0.8800 on 06/28/23 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 467.96 on 11/26/24 | 91.68 on 11/26/24 |
| 1-Month | |||||
| %Chg | -10.02% since 05/26/23 | -11.66% since 10/25/24 | +13.14% since 10/25/24 | -2.23% since 10/25/24 | +2.64% since 10/25/24 |
| Low | 0.7110 on 06/27/23 | 257.80 on 11/26/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.9599 on 06/05/23 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -15.50% since 03/28/23 | -14.31% since 08/26/24 | +21.77% since 08/26/24 | -3.23% since 08/26/24 | +18.70% since 08/26/24 |
| Low | 0.6910 on 05/03/23 | 257.80 on 11/26/24 | 47.55 on 09/09/24 | 445.00 on 11/21/24 | 76.69 on 08/27/24 |
| High | 1.3000 on 05/15/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +136.29% since 12/28/22 | -8.45% since 05/24/24 | +42.43% since 05/24/24 | +2.21% since 05/24/24 | +39.08% since 05/24/24 |
| Low | 0.3300 on 12/30/22 | 257.80 on 11/26/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 1.4000 on 02/01/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 26,614 | 158,319,600 | 119,398,784 | 116,137,848 | 112,400,728 |
| Shares Outstanding, K | 34,120 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 32,660,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -240,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 5,935,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 2.69 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 04/26/23 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.08 | 49.77 | 0.00 | 20.26 |